Three doses, three prices, and the whole agreement on one screen
The homepage prices three tirzepatide tiers by weekly dose band, and puts a comparison table under them showing what each includes: medication, doctor consult, syringes, shipping, and a zero against the membership line for all three. It then says, in a section it calls the whole agreement, that its fine print fits on one screen.
It also answers the question that follows: if a patient's dose rises past the top of a band, they move to the next published tier, and they see that price before anything is charged. That is a direct answer to the question most flat-rate sellers leave to a support email.
The struck-through originals
Each product page prints its price as a current price against an original one, and the originals are between two and two and a half times what is charged. A reader quoting the low figure is quoting a discount, and the page is at least explicit that it is one.
The homepage does not carry those anchors. It presents the three tiers as the whole list, which is the cleaner presentation and the one we have cited for the two tiers it covers.
Nobody is named, and the argument it makes about others
There is no operating company on this site. Two badges appear — a certification mark and a phrase about US compounding pharmacies — and neither is a legal entity or a named facility. No clinician is named either.
The homepage also argues against a competitor pricing shape: an advertised medication price with a required membership fee stacked on top of it. That is a real pattern in this market, and the seller is right that it exists. But the specific figures it uses are its own construction about unnamed rivals, not a measurement, and nothing here is derived from them.
Healthy Living Clinic's published pricing
| Medication | Price | Verified |
|---|---|---|
| Tirzepatide (compounded) | $99/moper month, all-in; the product page for this tier prints it as a current price against a struck-through $299.00 | September 2026source |
| Tirzepatide (compounded) | $149/moper month, all-in, month to month | September 2026source |
| Tirzepatide (compounded) | $199/moper month, all-in; the product page prints it as a current price against a struck-through $500.00 | September 2026source |
| Semaglutide (compounded) | $149/moper month; the product page prints it as a current price against a struck-through $299.00 | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See Healthy Living Clinic's current price →Good fit if
- Readers who want the fee position stated item by item before they see a price.
- Buyers who want to know which dose band they will land in, and what happens when they move up one.
- People starting at a microdose who want a tier priced for it rather than a full-strength rate.
- Anyone who prefers a whole-agreement summary to a terms page.
Look elsewhere if
- Readers who will not buy from a site that names no company at all.
- Buyers who want a named compounding pharmacy rather than a badge.
- Anyone who distrusts a price presented against a struck-through original of two to three times the amount.
- Readers who need a service-area list, or for whom an FDA warning letter is disqualifying.
How this review was verified
- Re-read the priced homepage and both product pages on 7 September 2026, comparing requested to effective URLs and running a nonsense path against the host in the same run, which returned a 404.
- Recorded the struck-through originals as well as the charged figures, and cited the homepage where it presents a tier without an anchor price.
- Ran a widened corporate-suffix pattern across every cached body on the host, proved first against a page known to name a company; it returned nothing here.
- Read the competitor-pricing argument in full and excluded its figures from every stored value.
- Screened the brand against FDA's live warning-letter datatable with a positive control and a nonsense negative control in the same invocation. ⛔ The letter FDA publishes for this seller carries no MARCS reference number in its own slug, so none is recorded rather than invented; the letter page itself was re-fetched and returned 200 with a title matching the name and the issue date.